Zevalin Indium (111In) IV injection set, containing Ibritumomab tiuxetan (genetical recombination) and indium chloride (111In), is a radioimmunotherapy treatment from Mundipharma for non-Hodgkin’s lymphoma. The indium-111 component is used for imaging to determine the drug’s biodistribution before therapy. This set has a YJ code of 4300450G1027 and a standard of One set.
Zevalin Indium (111In) IV injection set
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →